Craig Taylor

Craig Taylor is a Health2047 Advisor and the head of life science investments at Alloy Ventures. His career in venture capital began in 1977, and since co-founding Alloy Ventures in 1996, he and his partners have invested in over one hundred companies. Most recently, Craig has focused on investing in life science companies that span research tools, diagnostics, pharmaceuticals, medical devices and other technology with applications in biology. His personal interests and areas of expertise have shifted towards research tools that enable new insights into biology and the application of new biological knowledge. Craig holds a BA and MA in Physics from Brown University and an MBA from Stanford University.